Sonitron acquires 40,000 Dhampur Bio Organics shares in open market
Promoter entity Sonitron Limited purchased 40,000 shares of Dhampur Bio Organics in two open market deals on August 5 and 6, 2026. The acquisitions increased its holding to 17.353% of the total voting capital, with no encumbrances on the new shares.

*this image is generated using AI for illustrative purposes only.
Dhampur Bio Organics Limited’s promoter group entity, Sonitron Limited, acquired a total of 40,000 equity shares in two separate open market transactions during the first week of August 2026. The acquisitions, executed on August 05 and August 06, 2026, increased Sonitron’s aggregate holding to 1,15,20,499 shares, representing 17.353% of the company’s total share and voting capital. The disclosures were filed with the BSE Limited and the National Stock Exchange of India Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Two-Tranche Acquisition Details
Sonitron Limited, headquartered in New Delhi, conducted the purchases across two consecutive trading sessions. Mukul Sharma, Director of Sonitron Limited (DIN: 00078995), signed the disclosure forms dated August 06, 2026, from Mumbai. The first tranche involved the purchase of 25,000 equity shares on August 05, 2026, accounting for 0.038% of the total share capital. The second tranche saw the acquisition of 15,000 equity shares on August 06, 2026, representing 0.022% of the total share capital. Both transactions were carried out through the open market mechanism.
The following table outlines the movement in Sonitron Limited’s shareholding:
| Metric: | Before First Acquisition | After First Acquisition (Aug 05, 2026) | After Second Acquisition (Aug 06, 2026) |
|---|---|---|---|
| Shares Carrying Voting Rights: | 1,14,80,499 | 1,15,05,499 | 1,15,20,499 |
| % of Total Share/Voting Capital: | 17.293% | 17.331% | 17.353% |
| % of Total Diluted Share/Voting Capital: | 17.293% | 17.331% | 17.353% |
| Shares Acquired (Tranche): | — | 25,000 (0.038%) | 15,000 (0.022%) |
Capital Structure and Regulatory Compliance
The equity share capital of Dhampur Bio Organics remained constant at 6,63,87,590 equity shares of ₹10 each throughout both transactions. Consequently, the total diluted share/voting capital also remained unchanged at 6,63,87,590 equity shares. Sonitron Limited confirmed that none of the acquired shares are subject to encumbrance, pledge, lien, or non-disposal undertaking. Furthermore, there are no outstanding warrants or convertible securities held by the acquirer.
The disclosures comply with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which requires promoter group entities to report changes in shareholding upon crossing specified thresholds. Ashu Rawat, Company Secretary & Compliance Officer of Dhampur Bio Organics Limited, intimated the exchanges about the receipt of these disclosures on August 07, 2026.
Historical Stock Returns for Dhampur Bio Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.20% | +19.88% | +3.57% | +18.16% | +53.09% | -30.20% |
What strategic rationale is driving Sonitron Limited's incremental accumulation of stakes in Dhampur Bio Organics?
Could these open market purchases signal an impending larger corporate action, such as a tender offer or merger proposal?
How might this increased promoter group holding impact the liquidity and price volatility of Dhampur Bio Organics shares in the near term?


































